Skip to Main Content

Author Details

Sharon J Pitteri
Stanford University
2003
92
38
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36725887Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.Oncogene2023
38026225Guanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer.iScience2023
37721437Correction to "Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents".ACS Nano2023
37550801ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.J Pathol2023
37813880The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer.Sci Rep2023
37455012Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry.J Thorac Oncol2023
37441441Proteomics analysis of urine and catheter-associated biofilms in spinal cord injury patients.Am J Clin Exp Urol2023
36725114Measuring the multifaceted roles of mucin-domain glycoproteins in cancer.Adv Cancer Res2023
36493779Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signature.Stem Cell Reports2023
35243415SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer.Cell Rep Med2022
35705534Author Correction: Discovery of indole-modified aptamers for highly specific recognition of protein glycoforms.Nat Commun2022
35098564Protein signatures to distinguish aggressive from indolent prostate cancer.Prostate2022
34853070Multiomics Analysis of Spatially Distinct Stromal Cells Reveals Tumor-Induced O-Glycosylation of the CDK4-pRB Axis in Fibroblasts at the Invasive Tumor Edge.Cancer Res2022
34879180Engineered Cell-Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple-Negative Breast Cancer in Mice.Adv Healthc Mater2022
33219316Plectin is a regulator of prostate cancer growth and metastasis.Oncogene2021
33828176Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay.Sci Rep2021
33908003Enrichment of Intact Glycopeptides Using Strong Anion Exchange and Electrostatic Repulsion Hydrophilic Interaction Chromatography.Methods Mol Biol2021
33713600Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer.Cell Chem Biol2021
33583771A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-Based Glycoproteomics.Mol Cell Proteomics2021
34876561Discovery of indole-modified aptamers for highly specific recognition of protein glycoforms.Nat Commun2021
34711841Oncogene-mediated metabolic gene signature predicts breast cancer outcome.NPJ Breast Cancer2021
34172788MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer.Sci Rep2021
33288843Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.Br J Cancer2021
33140851Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.Hepatology2021
33139797Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer.Br J Cancer2021
32347709Reconstructed Apoptotic Bodies as Targeted "Nano Decoys" to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.ACS Nano2020
31932422Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.Proc Natl Acad Sci U S A2020
31398365LARP1 binding to hepatitis C virus particles is correlated with intracellular retention of viral infectivity.Virus Res2019
31297369Proteomic Identification and Time-Course Monitoring of Secreted Proteins During Expansion of Human Mesenchymal Stem/Stromal in Stirred-Tank Bioreactor.Front Bioeng Biotechnol2019
29351928Mapping and Quantification of Over 2000 O-linked Glycopeptides in Activated Human T Cells with Isotope-Targeted Glycoproteomics (Isotag).Mol Cell Proteomics2018
30200768Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer.J Proteome Res2018
30346694Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.ACS Nano2018
30510260Honey bee Royalactin unlocks conserved pluripotency pathway in mammals.Nat Commun2018
30272647CRISPR-Mediated Reorganization of Chromatin Loop Structure.J Vis Exp2018
29361466Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.Cell Syst2018
29695737Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.Sci Rep2018
29443976How many human proteoforms are there?Nat Chem Biol2018
29116467Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.Breast Cancer Res Treat2018
28703221Manipulation of nuclear architecture through CRISPR-mediated chromosomal looping.Nat Commun2017
28199111Parallel Comparison of N-Linked Glycopeptide Enrichment Techniques Reveals Extensive Glycoproteomic Analysis of Plasma Enabled by SAX-ERLIC.J Proteome Res2017
28188526Multi-Lectin Affinity Chromatography for Separation, Identification, and Quantitation of Intact Protein Glycoforms in Complex Biological Mixtures.Methods Mol Biol2017
28244757Development of IsoTaG, a Chemical Glycoproteomics Technique for Profiling Intact N- and O-Glycopeptides from Whole Cell Proteomes.J Proteome Res2017
29075496Assessing biological and technological variability in protein levels measured in pre-diagnostic plasma samples of women with breast cancer.Biomark Res2017
29090896The Exosome Total Isolation Chip.ACS Nano2017
26764010Proteomic Analysis of Epithelial to Mesenchymal Transition (EMT) Reveals Cross-talk between SNAIL and HDAC1 Proteins in Breast Cancer Cells.Mol Cell Proteomics2016
26519381FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potential.J Gen Virol2016
27694579Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.Proc Natl Acad Sci U S A2016
28458612Engineering cancer microenvironments for <i>in vitro</i> 3-D tumor models.Mater Today (Kidlington)2015
24174127Intact microRNA analysis using high resolution mass spectrometry.J Am Soc Mass Spectrom2014
23269276Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.Cancer Res2013
  • 1 - 50 of 92

Recommended Authors

Thomas L Fillmore
Pacific Northwest National Laboratory
Career Start Year 2011
Number of shared co-authors 3
Ankit Sinha
Max Planck Institute of Biochemistry
Career Start Year 2011
Number of shared co-authors 2
Vladimir Ignatchenko
Margaret Cancer Center
Career Start Year 2009
Number of shared co-authors 3
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Career Start Year 2009
Number of shared co-authors 7
Ben C Collins
Queen's University of Belfast
Career Start Year 2007
Number of shared co-authors 5
Athena A Schepmoes
Pacific Northwest National Laboratory
Career Start Year 2006
Number of shared co-authors 5
Therese R W Clauss
Pacific Northwest National Laboratory
Career Start Year 2005
Number of shared co-authors 5
Alex Ignatchenko
European Bioinformatics Institute (EMBL-EBI)
Career Start Year 2005
Number of shared co-authors 3
Bryan Krastins
Nuclea Biotechnologies
Career Start Year 2005
Number of shared co-authors 3
Hyoung-Joo Lee
Yonsei University
Career Start Year 2005
Number of shared co-authors 15
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 1
Tujin Shi
Pacific Northwest National Laboratory
Career Start Year 2004
Number of shared co-authors 4
Jon M Jacobs
Pacific Northwest National Laboratory
Career Start Year 2003
Number of shared co-authors 0
Melinda Rezeli
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 2002
Number of shared co-authors 7
Hanno Steen
Boston Children's Hospital, USA Harvard Medical School, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 5
Marina A Gritsenko
Pacific Northwest National Laboratory
Career Start Year 2000
Number of shared co-authors 6
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 9
Tao Liu
Pacific Northwest National Laboratory
Career Start Year 1998
Number of shared co-authors 12
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 6
Julius O Nyalwidhe
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 2
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 3
Christoph H Borchers
McGill University
Career Start Year 1994
Number of shared co-authors 20
Albert J R Heck
Utrecht University
Career Start Year 1991
Number of shared co-authors 10
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 14
Robert L Moritz
Institute for Systems Biology
Career Start Year 1985
Number of shared co-authors 23
Timothy J Griffin
University of Minnesota
Career Start Year 1985
Number of shared co-authors 7
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Career Start Year 1984
Number of shared co-authors 17
Rainer Bischoff
Groningen Research Institute of Pharmacy, University of Groningen
Career Start Year 1982
Number of shared co-authors 7
Steven A Carr
Broad Institute of MIT and Harvard
Career Start Year 1980
Number of shared co-authors 18
Edouard C Nice
Monash University
Career Start Year 1971
Number of shared co-authors 13

Collaborators

Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 29
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Co-authored papers 17
Carolyn R Bertozzi
Stanford University
Co-authored papers 7
Parag Mallick
Stanford University
Co-authored papers 5
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 5
Jacob J Kennedy
Co-authored papers 5
Aaron K Aragaki
Co-authored papers 3
JoAnn E Manson
Co-authored papers 3
Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 3
Raju Kucherlapati
Harvard Medical School
Co-authored papers 3
Rebecca D Jackson
Co-authored papers 3
Douglas H Phanstiel
University of North Carolina at Chapel Hill
Co-authored papers 2
Mary L Disis
University of Washington Medicine Cancer Vaccine Institute, University of Washington
Co-authored papers 2
Pei Wang
Co-authored papers 2
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 2
Michael Snyder
Stanford University
Co-authored papers 2
Gilbert S Omenn
and School of Public Health, University of Michigan ann arbor
Co-authored papers 2
Marina Hincapie
Co-authored papers 2
Nabeel Bardeesy
Massachusetts General Hospital
Co-authored papers 2
Ruedi Aebersold
Institute of Molecular Systems Biology, ETH Zurich
Co-authored papers 2
William S Hancock
Northeastern University
Co-authored papers 2
Hayley C Whitaker
University College London
Co-authored papers 2
Mark Gerstein
Yale University
Co-authored papers 1
Therese Wohlschlager
University of Salzburg
Co-authored papers 1
Daniel L Rubin
Stanford University.
Co-authored papers 1
Simin Liu
Co-authored papers 1
Mark M Davis
Co-authored papers 1
Michael C Jewett
Northwestern University
Co-authored papers 1
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 1
Harsha P Gunawardena
Co-authored papers 1
Release 1.2